Investing
The funding will aim to facilitate the company’s technology to treat conditions such as diabetes, insomnia, anxiety and obesity.
The new round was led by Motley Fool Ventures with participation from Zoll Medical Corporation, UH Ventures and Gray Ferry Capital.
The startup combines free assessments and in-person therapy with telehealth and digital care-coordination.
Also: Noteworth's $5 million seed round, Qualio's $11 million Series A and Cohere Health's $10 million Series A.
The funding will support NanoVation in developing a device which targets patients with chronic obstructive pulmonary disease (COPD).
The company received a De Novo clearance for its software in February, and is now looking to scale up its collaborations and product availability.
The chatbot-maker highlighted a jump from three customers to 24 over the course of a year.
Volition Capital and Greycroft led the round with participation from Horsley Bridge and Lerer Hippeau.
Ascension Ventures and .406 Ventures joined the financing round that was led by Cigna Ventures and MemorialCare Innovation Fund.
Movano's smartwatch-like wearable uses radio frequency technology to measure blood glucose without breaking the skin.